In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.